IQCJ-SCHIP1-AS1

Across TCGA pan-cancer cohorts, IQCJ-SCHIP1-AS1 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated IQCJ-SCHIP1-AS1 data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher IQCJ-SCHIP1-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated IQCJ-SCHIP1-AS1 expression acts as an unfavorable survival marker, although some lineages such as LUAD and CESC show a favorable association.

ESCA, LIHC, and LUAD are the cancer types where IQCJ-SCHIP1-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	DFS	Median	All	0.210	0.416	<.001	51	view →
LIHC	DFS	Tertile	II,III,IV	0.136	0.483	<.001	51	view →
LUAD	OS	Quartile	II,III,IV	0.692	0.511	.007	29	view →
CESC	DFS	Quartile	II,III,IV	0.936	0.722	.013	28	view →
SKCM	OS	Tertile	III,IV	0.961	0.772	.005	25	view →
LUSC	DFS	Median	IV	0.134	0.827	.014	20	view →
UVM	OS	Tertile	All	0.292	0.674	.035	18	view →
ACC	DFS	Tertile	II,III,IV	0.107	0.514	.013	18	view →
MESO	OS	Tertile	III,IV	0.371	0.572	.019	15	view →
UCEC	DFS	Tertile	III,IV	0.710	0.818	.033	12	view →
KICH	DFS	Tertile	All	0.335	0.884	.008	9	view →
HNSC	OS	Median	All	0.626	0.770	.011	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

IQCJ-SCHIP1-AS1–ESCA (DFS)

Open the ESCA breakdown →